Moutih Rafei
Chief Tech/Sci/R&D Officer presso DEFENCE THERAPEUTICS INC.
Patrimonio netto: 87 500 $ in data 31/03/2024
Posizioni attive di Moutih Rafei
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| DEFENCE THERAPEUTICS INC. | Director/Board Member | 05/01/2021 | - |
| Chief Tech/Sci/R&D Officer | 09/10/2020 | - | |
| University of Montréal | Corporate Officer/Principal | - | - |
Storia della carriera di Moutih Rafei
Precedenti posizioni note di Moutih Rafei
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
IntelliStem Technologies, Inc.
 IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Chief Tech/Sci/R&D Officer | - | 01/08/2023 |
| Founder | - | 01/08/2023 |
Formazione di Moutih Rafei
| McGill University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Canada | 4 |
| 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
IntelliStem Technologies, Inc.
IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Health Technology |
| Defence Therapeutics Inc |
- Borsa valori
- Insiders
- Moutih Rafei
- Esperienza
